Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogen (NEOG) Other financing activities: 2010-2025

Historic Other financing activities for Neogen (NEOG) over the last 12 years, with Aug 2025 value amounting to $5.0 million.

  • Neogen's Other financing activities rose 24.61% to $5.0 million in Q3 2025 from the same period last year, while for Aug 2025 it was $18.3 million, marking a year-over-year increase of 21.09%. This contributed to the annual value of $17.3 million for FY2025, which is 25.59% up from last year.
  • Latest data reveals that Neogen reported Other financing activities of $5.0 million as of Q3 2025, which was down 13.01% from $5.7 million recorded in Q2 2025.
  • In the past 5 years, Neogen's Other financing activities ranged from a high of $5.7 million in Q2 2025 and a low of $1.9 million during Q1 2022.
  • Moreover, its 3-year median value for Other financing activities was $3.8 million (2024), whereas its average is $3.9 million.
  • Its Other financing activities has fluctuated over the past 5 years, first skyrocketed by 53.08% in 2023, then fell by 0.77% in 2024.
  • Quarterly analysis of 4 years shows Neogen's Other financing activities stood at $2.6 million in 2022, then surged by 33.14% to $3.5 million in 2023, then declined by 0.77% to $3.5 million in 2024, then rose by 24.61% to $5.0 million in 2025.
  • Its Other financing activities stands at $5.0 million for Q3 2025, versus $5.7 million for Q2 2025 and $4.1 million for Q1 2025.